Clinical Trial & Drug Data (beta): Research Capabilities Overview – Help Center

Clinical Trial & Drug Data is in open beta. Some details in this article may change as the product evolves during the beta period.

Common Ways to Use Clinical Trial & Drug Data

If you track drug pipelines, clinical trials, or regulatory activity, you're probably used to pulling structured data from one set of tools, then switching to AlphaSense separately for market context: broker research, expert calls, filings, and news. Clinical Trial & Drug Data (Clinical Trial & Drug Data) closes that gap. It brings structured clinical, regulatory, and drug data directly into AlphaSense, connected through six entity profiles (Drug, Indication, Company, Therapy Area, Target, and Mode of Action) and linked to the premium content you already use.

Clinical Trial & Drug Data supports a range of research tasks, including:

Assess a competitive landscape. See which companies are developing what in a therapy area, how their trials compare, and what's changed recently, all in one connected view instead of several.
Research a company or asset before a meeting. Pull together a company's pipeline, trial activity, and regulatory history in a single profile to prepare quickly for a call or briefing.
Build a landscape view or diligence readout. Filter down to the records you need, then export or reference them directly in the deliverable you're producing, without re-keying data from another tool.

Getting Started with SuperAnalyst

Instead of researching each question separately and then stitching the findings together yourself, use SuperAnalyst to ask a multi-step research question directly. SuperAnalyst returns a synthesized answer that draws on both curated trial and drug data and AlphaSense's premium content, with citations back to the behind each part of the answer.

To run a query in SuperAnalyst:

Open SuperAnalyst.
Enter your research question in natural language. For example: "What does the Phase 3 pipeline look like for GLP-1 receptor agonists in obesity, and which companies have had recent regulatory activity?"
Review the synthesized answer. Each part is grounded in either a source document or a related Life Sciences entity.
Select a citation to open the underlying entity profile, trial record, or regulatory document for deeper research or verification.

SuperAnalyst and Clinical Trial & Drug Data citations are still in beta. Some citation types, particularly links to specific profile sections, are still being refined.

From here, dig deeper by reviewing:

Entity Profiles
Access Product and Clinical Trial Data from Company Profiles

Entity Profiles

Entity profiles are the fastest way to assess a competitive landscape: instead of researching a drug, its sponsor, and its trials separately, you get a connected view of all of it at once. Clinical Trial & Drug Data organizes data around six connected entity types, and each profile links to the others, so you can move from a drug to its indication, sponsor, target, or mechanism without starting a new search.

Entity Profiles cover: Drug, Indication, Company, Therapy Area, Target, and Mode of Action.

Each profile brings together related approved products, pipeline assets, clinical trials, companies, indications, targets, and regulatory information for that entity. You can open an entity profile from a company or keyword search, or from a citation in a SuperAnalyst answer.

Charts

Entity profiles include preconfigured charts that summarize approved products and clinical trials, for example, breakdowns by therapy area, indication, product type, target, mechanism of action, sponsor, clinical phase, or patent and exclusivity expiration.

Deep Linking Between Entities

Move directly between related entities, including Drug, Indication, Company, Therapy Area, Target, and Mode of Action, without starting a new search. Profiles link to related trial records, regulatory documents, and supported drug or brand views.

Access Product and Clinical Trial Data from Company Profiles

Use these views when you need to size up a company's development strategy at a glance, whether for a competitive review, meeting prep, or a diligence check.

To view a company's portfolio and pipeline:

Open a company profile.
In the left-hand toolbar, scroll to the Life Sciences section.
Select Products to view the company's marketed drugs, or Clinical Trials to view its drugs still in development.

These views include:

Summary metrics, charts, and filterable tables for approved products and pipeline assets
Breakdowns by development phase, trial status, and regulatory activity
Patent and exclusivity exposure where available
U.S. and European coverage
Links to related drugs, indications, companies, trials, and source documents

Screen, Filter, and Export Data

Rather than re-filtering the same datasets every time you research a therapy area or track a competitor, use the data screener to narrow large regulatory and clinical-trial datasets down to the question you're researching. Save a filter configuration you'll want again as a view, then export the results when you're ready to use them elsewhere.

Filtering

Available filtering options include:

Quick filters and column-level filters
Multi-filter combinations
Sorting and pagination
Filters that persist as you navigate

Saved Views

Create, apply, rename, edit, and delete named saved views. A saved view stores your selected table, quick-filter, and column-filter configuration. It doesn't add new data, and it's tied to the specific table it was created from.

CSV Export

When your research needs to become a deliverable export the underlying data directly instead of re-keying it. CSV export is available from supported approved-product, regulatory approval, orphan-designation, patent and exclusivity, and clinical-trial tables. The exported file reflects any filters you've applied and includes the complete matching result set, not just the rows currently visible on screen.

Data Coverage

Clinical Trial & Drug Data combines several categories of structured data:

U.S. patent and exclusivity data: Drug patent listings and expiration dates, regulatory exclusivity types and expiration dates, biosimilar and interchangeability relationships, orphan designations, and available generic-challenge activity.
Approvals and clinical trials: U.S. and European drug approvals and clinical-trial records, enriched with target, mechanism of action, indication, and therapy area classifications.
China coverage: Clinical-trial records and drug approvals specific to China, including trial IDs, sponsors, phase, and status for trials, and approval details, manufacturers, and product information for approvals. Records are linked to related drugs, companies, and indications where a mapping is available.

Data Sources and Security

Clinical Trial & Drug Data is compiled from public regulatory and clinical-trial sources, including the FDA, EMA, ClinicalTrials.gov, EUCTIS/EudraCT, and China's NMPA and ChiCTR registries, along with scientific reference sources used to classify drugs, targets, and indications consistently across regions.

FAQ

Is Clinical Trial and Drug Data available to all AlphaSense customers?

Not yet. Access is rolling out in phases to Life Sciences and Healthcare Consulting customers starting September 15, 2026, with broader availability planned for early October.

Will the interface change during the beta?

Yes. Clinical Trial and Drug Data is in beta, and AlphaSense is actively refining the experience based on customer feedback. This article will be updated as features change.

Can I request access before my organization's scheduled rollout date?

Contact your account team to ask about early access.

In this article